|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Cash Flows From Operating Activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Loss from written off property and equipment | ||
| Depreciation and amortization | ||
| Provision for credit losses | ||
| Share-based compensation | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Accounts receivable - related party | ||
| Inventories | ||
| Deferred contract costs | ||
| Due from related parties | ||
| Prepayments and other current assets | ||
| Long term deposits | ||
| Accounts payable | ||
| Deferred revenue | ||
| Due to related parties | ||
| Accrued expenses and other liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Acquisition of property and equipment | ||
| Capital injection from minority shareholder | ||
| Net cash used in investing activities | ||
| Cash Flows From Financing Activities: | ||
| Proceeds from bank loans | ||
| Repayment of bank loans | ||
| Sales of public shares through public offering | ||
| Net cash provided by financing activities | ||
| Effect of exchange rate changes on cash and restricted cash | ||
| Net increase (decrease) in cash and restricted cash | ||
| Cash and restricted cash at beginning of the year | ||
| Cash and restricted cash at end of the year | ||
| Supplemental Cash Flow Information | ||
| Cash paid for interest expense | ||
| The following table identifies the balance sheet line items included in cash and restricted cash presented in the consolidated statements of cash flows: | ||
| Cash | ||
| Restricted cash | ||
| Total | ||
| Share issuance under equity line of credit included in deferred offering cost |
Loading...